A major biotech company is leaving the Bay Area.
Pfizer is abandoning its research site at 181 Oyster Point Blvd. in South San Francisco. The biotech company will move out of the building by the end of April, the San Francisco Chronicle reported. (The Chronicle and SFGATE are both owned by Hearst but have separate newsrooms.) The closure comes after the company sought a tenant to sublease the 164,000-square-foot facility, the outlet said.
“After careful evaluation, Pfizer has decided to close its South San Francisco office as the office space is currently underutilized,” company spokesperson Jerica Pitts told the Chronicle in a statement…